LFMD vs TDOC
LFMD: LifeMD is a vertically integrated, subscription-based telehealth platform that combines virtual medical care with internal pharmacy fulfillment to provide accessible, longitudinal patient care. TDOC: A global leader in virtual care services, connecting patients to providers for a wide range of medical, specialty, and chronic condition management needs.
Side-by-side fundamentals
| Metric | LFMD | TDOC | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $2.65 | $5.54 | |
| Market cap | $128M | $1.0B | |
| P/E as of 2026-10-08 | 311.76 | n/a | |
| Net margin FY2025, SEC XBRL | +7.4% | -7.9% | LFMD higher |
| Gross margin FY2025, SEC XBRL | +85.7% | n/a | |
| Operating margin FY2025, SEC XBRL | -4.0% | -10.4% | LFMD higher |
| ROE FY2025, SEC XBRL | +62.0% | -14.5% | LFMD higher |
| ROA FY2025, SEC XBRL | +20.4% | -7.0% | LFMD higher |
| Debt / equity as of 2026-09-03 | 0.00 | 0.76 | LFMD lower |
| Revenue growth (YoY) as of 2026-09-03 | -16.7% | -2.1% | TDOC higher |
| Revenue CAGR (3y) SEC XBRL | +17.7% | +1.7% | LFMD higher |
| Dividend yield as of 2026-09-03 | +1.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | n/a | 0 | |
| Beta as of 2026-09-03 | 1.64 | 1.34 | |
| 1-year return as of 2026-10-08 close | -60.1% | -39.1% | TDOC higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.